DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 253, doi. 10.1111/imm.13667
- By:
- Publication type:
- Article
Works matching IS 00192805 AND DT 2023 AND VI 170 AND IP 2
Results: 11
1
2
βhCG mediates immune suppression through upregulation of CD11b<sup>+</sup>Gr1<sup>+</sup> myeloid derived suppressor cells, CD206<sup>+</sup>M2 macrophages, and CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T‐cells in BRCA1 deficient breast cancers
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 270, doi. 10.1111/imm.13673
- By:
- Publication type:
- Article
3
6‐Mercaptopurine potently inhibits recruitment of SHP2 by phosphorylated PD‐1 to inhibit PD‐1 signalling and enhance T cell function.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 230, doi. 10.1111/imm.13671
- By:
- Publication type:
- Article
4
Polymorphonuclear myeloid‐derived suppressor cells play a proinflammatory role via TNF‐α<sup>+</sup> B cells through BAFF/BTK/NF‐κB signalling pathway in the pathogenesis of collagen‐induced arthritis mice.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 286, doi. 10.1111/imm.13668
- By:
- Publication type:
- Article
5
Activation of Inflammasome complex in nasopharyngeal epithelial cells from patients with Coronavirus disease 2019 contributes to inflammatory state and worse disease outcomes.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 243, doi. 10.1111/imm.13666
- By:
- Publication type:
- Article
6
Autoantigen‐selected B cells are bystanders in spontaneous T cell‐driven experimental autoimmune hepatitis.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 214, doi. 10.1111/imm.13665
- By:
- Publication type:
- Article
7
Complement: Functions, location and implications.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 180, doi. 10.1111/imm.13663
- By:
- Publication type:
- Article
8
Inhibiting N‐glycan processing increases the antibody binding affinity and effector function of human natural killer cells.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 202, doi. 10.1111/imm.13662
- By:
- Publication type:
- Article
9
Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 193, doi. 10.1111/imm.13661
- By:
- Publication type:
- Article
10
Mucosal‐associated invariant T cells in digestive tract: Local guardians or destroyers?
- Published in:
- Immunology, 2023, v. 170, n. 2, p. 167, doi. 10.1111/imm.13653
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Immunology, 2023, v. 170, n. 2, p. i, doi. 10.1111/imm.13510
- Publication type:
- Article